Trademarkia Logo

Canada

C$
Trademark Search in Canada
LUYE

View On IC.GC.CA

LUYE
REGISTERED

on 16 Feb 2022

Last Applicant/ Owned by

SHANDONG LUYE PHARMACEUTICAL CO. LTD

NO.15 CHUANGYE ROADYANTAI HIGH-TECH ZONESHANDONG PROVINCE

CN

Serial Number

1920256 filed on 17th Sept 2018

Registration Number

TMA1120382 registered on 16th Feb 2022

Registration expiry Date

16th Feb 2032

Correspondent Address

NEOMARK LTD.

7450 rue Saint-HubertMontréal

QUEBEC

CA

H2R2N3

LUYE

Trademark usage description

medical preparations for the treatment of psychological and mental disorders, depression, schizophrenia, bipolar disorder, hyperlipidemia, dyslipidemi Read More

Classification Information

Class [001]
Chemicals and adhesives

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Medical preparations for the treatment of psychological and mental disorders, depression, schizophrenia, bipolar disorder, hyperlipidemia, dyslipidemia, Parkinson's disease, Restless Legs Syndrome, cancer, endometriosis, dysfunctional uterine bleeding; medicines for human purposes and drugs for medical purposes namely, sodium aescinate injections for the treatment of cerebral edema and edema caused by trauma or operations and of venous back flow obstruction diseases, sodium glycididazole injections in the nature of radiosensitizer for the radiotherapy of solid tumors such as head and neck tumor, lung cancer, and esophageal cancer, and reduced glutathione injections for the treatment of alcoholic fatty liver, alcoholic liver fibrosis, alcoholic liver cirrhosis, acute alcoholic hepatitis, poisoning by radiotherapy, drugs and chemicals; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; first aid kits; wadding for medical purposes; gases for medical use; diagnostic preparations for medical laboratory use; pharmaceutical preparations, chemicopharmaceutical preparations, and chemical preparations for pharmaceutical purposes, namely, sodium aescinate tablets for the treatment of venous edema and soft tissue swelling due to various causes, smectite dispersible tablets and smectite powder sachets for the treatment of acute and chronic bacillary diarrhea of adults and children and for the treatment of pains caused by gullet, stomach and duodenum diseases but not used for spasmolysant, and elcatonin injections for the treatment of bone pains caused by osteoporosis, of hypercalcaemia, and of scleromalacia; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; surgical dressings; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; suppositories for veterinary purposes; castor oil for medical purposes; disinfectants for medical apparatus and instruments; fly destroying preparations; dental lacquer; fly catching adhesives; capsules for pharmaceutical purposes, namely, pantoprazole pellets capsules for the treatment of duodenal ulcer, gastric ulcer and acute pathological changes of gastric mucosa, reflux esophagitis and Zollinger-Ellison Syndrome; antiparasitics; therapeutic medicated bath preparations; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; nutritional supplements for general health and well-being; pesticides for horticultural purposes.

Classification kind code

11

Mark Details

Serial Number

1920256

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 24th Nov 2021		Registration Pending
Submitted for opposition 191
on 24th Nov 2021		Registration Fee Notice Sent
Submitted for opposition 42
on 28th Jul 2021		Advertised
Submitted for opposition 26
on 29th Jun 2021		Approved
Submitted for opposition 27
on 29th Jun 2021		Approval Notice Sent
Submitted for opposition 22
on 27th May 2021		Search Recorded
Submitted for opposition 20
on 27th May 2021		Examiner's First Report
Submitted for opposition 31
on 20th Sept 2018		Formalized
Submitted for opposition 1
on 18th Sept 2018		Created
Submitted for opposition 30
on 17th Sept 2018		Filed